$Versartis, Inc.(VSAR)$ 内部交易: 2017-12-05,Director,AKKARAJU SRINIVAS ,买入,42895普通股, $2.00
$Versartis, Inc.(VSAR)$ 内部交易: 2017-12-04,Director,AKKARAJU SRINIVAS ,买入,513872普通股, $2.21
$Versartis, Inc.(VSAR)$ 内部交易: 2017-12-01,Director,AKKARAJU SRINIVAS ,买入,419700普通股, $2.13
$Versartis, Inc.(VSAR)$ 8-K - Current report Filed: 2017-12-04 AccNo: 0001193125-17-360299 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Versartis, Inc.(VSAR)$ 8-K - Current report Filed: 2017-11-22 AccNo: 0001193125-17-350794 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Versartis, Inc.(VSAR)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-09 AccNo: 0001564590-17-023222 Size: 3 MB 网页链接
$Versartis, Inc.(VSAR)$ 8-K - Current report Filed: 2017-10-26 AccNo: 0001564590-17-020178 Size: 195 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Versartis, Inc.(VSAR)$ 内部交易: 2017-10-19,COO and CFO,Brumm Joshua T ,卖出,1326普通股, $2.55
$Versartis, Inc.(VSAR)$ 内部交易: 2017-10-19,Chief Medical Officer,Hislop Colin ,卖出,667普通股, $2.55
$Versartis, Inc.(VSAR)$ 内部交易: 2017-10-19,SVP and General Counsel,Ward Shane ,卖出,776普通股, $2.55